TrialRMD open2025

Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteria.

Ioannis Parodis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.